Inhibitory effect of metastasis by combined administration with interleukin-2 and sizofiran, a single glucan--immunohistochemical study.

@article{Kano1996InhibitoryEO,
  title={Inhibitory effect of metastasis by combined administration with interleukin-2 and sizofiran, a single glucan--immunohistochemical study.},
  author={Yoko Kano and Hideki Kakuta and Junko Hashimoto},
  journal={Biotherapy},
  year={1996},
  volume={9 4},
  pages={263-9}
}
Innovations in methods of combined administration with other BRM or chemotherapeutic drugs have been discussed. We have reported that combined administration with recombinant interleukin-2 (rIL-2) and sizofiran (SPG) is effective in prolonging survival time of C57BL/6 mice intraperitoneally inoculated with EL-4 lymphoma. The immunomechanisms of the combined… CONTINUE READING